Psychiatry Research
Volume 133, Issue 2 , Pages 197-203 , 28 February 2005

Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission

  • Jan Vevera

      Affiliations

    • Psychiatric Clinic, First Faculty of Medicine of Charles University, Ke Karlovu 11, 120 00 Prague, Czech Republic
    • School of Public Health, University of California at Berkeley, Berkeley, CA, USA
    • Corresponding Author InformationCorresponding author. Psychiatric Clinic, First Medical Faculty, Charles University, Ke Karlovu 11, 120 00 Prague, Czech Republic.
    • ,
  • Zdenĕk Fišar

      Affiliations

    • Psychiatric Clinic, First Faculty of Medicine of Charles University, Ke Karlovu 11, 120 00 Prague, Czech Republic
    • ,
  • Tomáš Kvasnička

      Affiliations

    • Third Medical Department, Clinical Department of Endocrinology and Metabolism, First Faculty of Medicine Charles University, Prague, Czech Republic
    • ,
  • Hanuš Zdeněk

      Affiliations

    • Psychiatric Clinic, First Faculty of Medicine of Charles University, Ke Karlovu 11, 120 00 Prague, Czech Republic
    • ,
  • Lucie Stárková

      Affiliations

    • Psychiatric Clinic, First Faculty of Medicine of Charles University, Ke Karlovu 11, 120 00 Prague, Czech Republic
    • ,
  • Richard Češka

      Affiliations

    • Third Medical Department, Clinical Department of Endocrinology and Metabolism, First Faculty of Medicine Charles University, Prague, Czech Republic
    • ,
  • Hana Papežová

      Affiliations

    • Psychiatric Clinic, First Faculty of Medicine of Charles University, Ke Karlovu 11, 120 00 Prague, Czech Republic

Received 24 February 2004 ,Revised 24 September 2004 ,Accepted 26 November 2004.

References 

  1. Agrawal D, Subramoniam A, Afaq F. Influence of hexachlorocyclohexane on phosphoinositides in rat erythrocyte membranes and brain. Toxicology. 1995;95:135–140
  2. Balon R. Cholesterol, mental illness and violence. Psychiatrie. 2000;2:83–90
  3. Bartlett GR. Phosphorus assay in column chromatography. Journal of Biological Chemistry. 1959;234:466–468
  4. Chin JH, Parsons LM, Goldstein DB. Increased cholesterol content of erythrocyte and brain membranes in ethanol-tolerant mice. Biochimica et Biophysica Acta. 1978;513:358–363
  5. Deisenhammer EA, Kramer-Reinstadler K, Liensberger D, Kemmler G, Hinterhuber H, Fleischhacker W. No evidence for an association between serum cholesterol and the course of depression and suicidality. Psychiatry Research. 2004;121:253–261
  6. Delva NJ, Matthews DR, Cowen PJ. Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs. Biological Psychiatry. 1996;39:100–106
  7. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Archives of Biochemistry and Biophysics. 1963;100:119–130
  8. Engelberg H. Low serum cholesterol and suicide. Lancet. 1992;339:727–729
  9. Haase J, Killian AM, Magnani F, Williams C. Regulation of the serotonin transporter by interacting proteins. Biochemical Society Transactions. 2001;29:722–728
  10. Hibbeln JR, Umhau JC, George DT, Shoaf SE, Linnoila M, Salem N. Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids. American Journal of Clinical Nutrition. 2000;71(1 Suppl.):331S–338S
  11. Huang TL, Wu SC, Chiang YS, Chen JF. Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder. Psychiatry Research. 2003;118:147–153
  12. Kirsch C, Eckert GP, Mueller WE. Statin effects on cholesterol micro-domains in brain plasma membranes. Biochemical Pharmacology. 2003;65:843–856
  13. Koul A, Prasad R. Extraction of membrane lipids. In:  Prasad R editors. Manual on membrane lipids. Berlin, Heidelberg, New York: Springer-Verlag; 1996;p. 35–37
  14. Krikava K, Kalla K, Yamamotova A, Rokyta R. Blood serum changes in patients with pain during bone fractures and acute pancreatitis. Neuroendocrinology Letters. 2004;25:62–69
  15. Lakowicz JR. Principles of fluorescence spectroscopy. Second edition. New York: Kluwer Academic/Plenum Publishers; 1999;
  16. Lecrubier Y, Braconnier A, Said S, Payan C. The Impulsivity Rating Scale (IRS): preliminary results. European Psychiatry. 1995;7:331–338
  17. Locatelli S, Lutjohann D, Schmidt HH, Otto C, Beisiegel U, von Bergmann K. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Archives of Neurology. 2002;59:213–216
  18. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. British Medical Journal. 1990;301:309–314
  19. Muldoon MF, Manuck SB, Mendelsohn AB, Kaplan JR, Belle SH. Cholesterol reduction and non-illness mortality: meta-analysis of randomized clinical trials. British Medical Journal. 2001;322:11–15
  20. Ormiston T, Wolkowitz OM, Reus VI, Manfredi F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics. 2003;44:412–414
  21. Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Alpert JE, Nierenberg AA, et al. Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Research. 2003;118:137–145
  22. Ringo DL, Lindley SE, Faull KF, Faustman WO. Cholesterol and serotonin: seeking a possible link between blood cholesterol and CSF 5-HIAA. Biological Psychiatry. 1994;35:957–959
  23. Saheki A, Terasaki T, Tamai I, Tsuji A. In vivo and in vitro blood-brain barrier transport of 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG CoA) reductase inhibitors. Pharmaceutical Research. 1994;11:305–311
  24. Sarchiapone M, Camardese G, Roy A, Della Casa S, Satta MA, Gonzalez B, et al. Cholesterol and serotonin indices in depressed and suicidal patients. Journal of Affective Disorders. 2001;62:217–219
  25. Scanlon SM, Williams DC, Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry. 2001;3:10507–10513
  26. Tanskanen A, Vartiainen E, Tuomilehto J, Viinamaki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. American Journal of Psychiatry. 2000;157:648–650
  27. Terao T, Nakamura J, Yoshimura R, Ohmori O, Takahashi N, Kojima H, et al. Relationship between serum cholesterol levels and meta‐chlorophenylpiperazine‐induced cortisol responses in healthy men and women. Psychiatry Research. 2000;96:167–173
  28. Tuomisto J, Tukiainen E, Ahlfors UG. Decreased uptake of 5‐hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology. 1979;65:141–147
  29. Vevera J, Zukov I, Morcinek T, Papezova H. Cholesterol concentrations in violent and non‐violent women suicide attempters. European Psychiatry. 2003;18:23–27
  30. Volavka J. Neurotransmitters, hormones, and genes. In: Neurobiology of violence. 2nd ed.. Washington, DC: American Psychiatric Press; 2002;p. 45–81

PII: S0165-1781(04)00302-6

doi: 10.1016/j.psychres.2004.11.005

Psychiatry Research
Volume 133, Issue 2 , Pages 197-203 , 28 February 2005

Article Tools

* Image Usage & Resolution